BDRX Projected Dividend Yield
Sponsored ADR (New)/Biodexa Pharmaceuticals plc ( NASDAQ : BDRX )Biodexa Pharmaceuticals is a holding company. Through its subsidiaries, Co. is focused on the research and development of medicines using its drug delivery technologies. These technologies include Q-Sphera™ platform, a disruptive polymer microsphere microtechnology used for sustained delivery to prolong and control the release of therapeutics over an extended period of time; MidaSolve™ platform, an oligosaccharide nanotechnology to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore™ platform, a gold nanoparticle nanotechnology used for targeting sites of disease by using either chemotherapeutic agents or immunotherapeutic agents. 20 YEAR PERFORMANCE RESULTS |
BDRX Dividend History Detail BDRX Dividend News BDRX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |